Manchester Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5K | Sell |
568
-15
| -3% | -$540 | ﹤0.01% | 713 |
|
|
2025
Q1 | $18.1K | Buy |
583
+175
| +43% | +$5.45K | ﹤0.01% | 728 |
|
|
2024
Q4 | $10.4K | Buy |
+408
| New | +$10.4K | ﹤0.01% | 801 |
|
|
2022
Q1 | – | Sell |
-238
| Closed | -$9K | – | 1090 |
|
|
2021
Q4 | $9K | Buy |
+238
| New | +$9K | ﹤0.01% | 579 |
|
|
2021
Q1 | – | Sell |
-33
| Closed | -$2K | – | 761 |
|
|
2020
Q4 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 617 |
|